Dicerna CEO talks market rivals after signing last partnership deal

Two of Greater Boston’s longtime biotech rivals, Dicerna Pharmaceuticals Inc. and Alnylam Pharmaceuticals, may have resolved their legal fights, but a battle for market dominance looms in 2020.